Logo image of TNON

TENON MEDICAL INC (TNON) Stock Fundamental Analysis

NASDAQ:TNON - US88066N3035 - Common Stock

1.49 USD
0 (0%)
Last: 8/22/2025, 8:00:02 PM
1.4804 USD
-0.01 (-0.64%)
After Hours: 8/22/2025, 8:00:02 PM
Fundamental Rating

3

Taking everything into account, TNON scores 3 out of 10 in our fundamental rating. TNON was compared to 185 industry peers in the Health Care Equipment & Supplies industry. While TNON seems to be doing ok healthwise, there are quite some concerns on its profitability. TNON is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

TNON had negative earnings in the past year.
TNON had a negative operating cash flow in the past year.
In the past 5 years TNON always reported negative net income.
In the past 5 years TNON always reported negative operating cash flow.
TNON Yearly Net Income VS EBIT VS OCF VS FCFTNON Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 -5M -10M -15M

1.2 Ratios

TNON's Return On Assets of -113.87% is on the low side compared to the rest of the industry. TNON is outperformed by 82.89% of its industry peers.
TNON has a worse Return On Equity (-188.53%) than 72.73% of its industry peers.
Industry RankSector Rank
ROA -113.87%
ROE -188.53%
ROIC N/A
ROA(3y)-185.03%
ROA(5y)-156.48%
ROE(3y)-844.8%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
TNON Yearly ROA, ROE, ROICTNON Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 0 -500 -1K -1.5K -2K

1.3 Margins

TNON has a Gross Margin of 45.44%. This is in the lower half of the industry: TNON underperforms 60.96% of its industry peers.
In the last couple of years the Gross Margin of TNON has declined.
TNON does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 45.44%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-8.76%
GM growth 5Y-8.18%
TNON Yearly Profit, Operating, Gross MarginsTNON Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024 0 -1K -2K -3K -4K

More info and screens

6

2. Health

2.1 Basic Checks

TNON does not have a ROIC to compare to the WACC, probably because it is not profitable.
TNON has more shares outstanding than it did 1 year ago.
Compared to 5 years ago, TNON has more shares outstanding
TNON has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
TNON Yearly Shares OutstandingTNON Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 1M 2M 3M
TNON Yearly Total Debt VS Total AssetsTNON Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M 10M

2.2 Solvency

Based on the Altman-Z score of -10.44, we must say that TNON is in the distress zone and has some risk of bankruptcy.
TNON has a worse Altman-Z score (-10.44) than 79.14% of its industry peers.
There is no outstanding debt for TNON. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z -10.44
ROIC/WACCN/A
WACC8.69%
TNON Yearly LT Debt VS Equity VS FCFTNON Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 2024 0 5M -5M -10M

2.3 Liquidity

A Current Ratio of 3.86 indicates that TNON has no problem at all paying its short term obligations.
Looking at the Current ratio, with a value of 3.86, TNON is in the better half of the industry, outperforming 67.91% of the companies in the same industry.
TNON has a Quick Ratio of 3.59. This indicates that TNON is financially healthy and has no problem in meeting its short term obligations.
Looking at the Quick ratio, with a value of 3.59, TNON is in the better half of the industry, outperforming 71.66% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 3.86
Quick Ratio 3.59
TNON Yearly Current Assets VS Current LiabilitesTNON Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 5M 10M 15M

More info and screens

6

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 78.63% over the past year.
The Revenue for TNON has decreased by -12.60% in the past year. This is quite bad
TNON shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 130.83% yearly.
EPS 1Y (TTM)78.63%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%95.59%
Revenue 1Y (TTM)-12.6%
Revenue growth 3Y173.6%
Revenue growth 5Y130.83%
Sales Q2Q%-37.4%

3.2 Future

The Earnings Per Share is expected to grow by 14.85% on average over the next years. This is quite good.
TNON is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 57.36% yearly.
EPS Next Y92.39%
EPS Next 2Y40.08%
EPS Next 3Y25.55%
EPS Next 5Y14.85%
Revenue Next Year24.48%
Revenue Next 2Y50.58%
Revenue Next 3Y64.91%
Revenue Next 5Y57.36%

3.3 Evolution

Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
TNON Yearly Revenue VS EstimatesTNON Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 10M 20M 30M 40M
TNON Yearly EPS VS EstimatesTNON Yearly EPS VS EstimatesYearly EPS VS Estimates 2022 2023 2024 2025 2026 2027 2028 2029 2030 0 -50 -100 -150

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

TNON reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Also next year TNON is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
TNON Price Earnings VS Forward Price EarningsTNON Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40 60

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
TNON Per share dataTNON EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -2 -4 -6

4.3 Compensation for Growth

A more expensive valuation may be justified as TNON's earnings are expected to grow with 25.55% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y40.08%
EPS Next 3Y25.55%

More info and screens

0

5. Dividend

5.1 Amount

TNON does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

TENON MEDICAL INC

NASDAQ:TNON (8/22/2025, 8:00:02 PM)

After market: 1.4804 -0.01 (-0.64%)

1.49

0 (0%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)08-13 2025-08-13/amc
Earnings (Next)11-11 2025-11-11/amc
Inst Owners2.05%
Inst Owner Change-71.39%
Ins Owners0.27%
Ins Owner Change0%
Market Cap13.23M
Analysts82.5
Price Target6.04 (305.37%)
Short Float %0.88%
Short Ratio0.01
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)17.85%
Min EPS beat(2)10.79%
Max EPS beat(2)24.91%
EPS beat(4)4
Avg EPS beat(4)13.41%
Min EPS beat(4)1.96%
Max EPS beat(4)24.91%
EPS beat(8)8
Avg EPS beat(8)21.32%
EPS beat(12)11
Avg EPS beat(12)17.92%
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-39.92%
Min Revenue beat(2)-40.64%
Max Revenue beat(2)-39.2%
Revenue beat(4)0
Avg Revenue beat(4)-38.69%
Min Revenue beat(4)-47.97%
Max Revenue beat(4)-26.94%
Revenue beat(8)0
Avg Revenue beat(8)-25.84%
Revenue beat(12)0
Avg Revenue beat(12)-22.46%
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)1.43%
PT rev (3m)-1.39%
EPS NQ rev (1m)8.05%
EPS NQ rev (3m)75.76%
EPS NY rev (1m)7.63%
EPS NY rev (3m)32.53%
Revenue NQ rev (1m)7.48%
Revenue NQ rev (3m)-24.93%
Revenue NY rev (1m)3.23%
Revenue NY rev (3m)-24.82%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 4.49
P/FCF N/A
P/OCF N/A
P/B 1.97
P/tB 1.97
EV/EBITDA N/A
EPS(TTM)-7.54
EYN/A
EPS(NY)-0.92
Fwd EYN/A
FCF(TTM)-1.13
FCFYN/A
OCF(TTM)-1.11
OCFYN/A
SpS0.33
BVpS0.76
TBVpS0.76
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -113.87%
ROE -188.53%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 45.44%
FCFM N/A
ROA(3y)-185.03%
ROA(5y)-156.48%
ROE(3y)-844.8%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-8.76%
GM growth 5Y-8.18%
F-Score4
Asset Turnover0.27
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 45.76%
Cap/Sales 8.79%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 3.86
Quick Ratio 3.59
Altman-Z -10.44
F-Score4
WACC8.69%
ROIC/WACCN/A
Cap/Depr(3y)391.88%
Cap/Depr(5y)N/A
Cap/Sales(3y)47.06%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)78.63%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%95.59%
EPS Next Y92.39%
EPS Next 2Y40.08%
EPS Next 3Y25.55%
EPS Next 5Y14.85%
Revenue 1Y (TTM)-12.6%
Revenue growth 3Y173.6%
Revenue growth 5Y130.83%
Sales Q2Q%-37.4%
Revenue Next Year24.48%
Revenue Next 2Y50.58%
Revenue Next 3Y64.91%
Revenue Next 5Y57.36%
EBIT growth 1Y7.02%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y30.22%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y27.55%
OCF growth 3YN/A
OCF growth 5YN/A